38561809|t|The endotoxin hypothesis of Alzheimer's disease.
38561809|a|Lipopolysaccharide (LPS) constitutes much of the surface of Gram-negative bacteria, and if LPS enters the human body or brain can induce inflammation and act as an endotoxin. We outline the hypothesis here that LPS may contribute to the pathophysiology of Alzheimer's disease (AD) via peripheral infections or gut dysfunction elevating LPS levels in blood and brain, which promotes: amyloid pathology, tau pathology and microglial activation, contributing to the neurodegeneration of AD. The evidence supporting this hypothesis includes: i) blood and brain levels of LPS are elevated in AD patients, ii) AD risk factors increase LPS levels or response, iii) LPS induces Abeta expression, aggregation, inflammation and neurotoxicity, iv) LPS induces TAU phosphorylation, aggregation and spreading, v) LPS induces microglial priming, activation and neurotoxicity, and vi) blood LPS induces loss of synapses, neurons and memory in AD mouse models, and cognitive dysfunction in humans. However, to test the hypothesis, it is necessary to test whether reducing blood LPS reduces AD risk or progression. If the LPS endotoxin hypothesis is correct, then treatments might include: reducing infections, changing gut microbiome, reducing leaky gut, decreasing blood LPS, or blocking LPS response.
38561809	28	47	Alzheimer's disease	Disease	MESH:D000544
38561809	49	67	Lipopolysaccharide	Chemical	MESH:D008070
38561809	69	72	LPS	Chemical	MESH:D008070
38561809	140	143	LPS	Chemical	MESH:D008070
38561809	155	160	human	Species	9606
38561809	186	198	inflammation	Disease	MESH:D007249
38561809	260	263	LPS	Chemical	MESH:D008070
38561809	305	324	Alzheimer's disease	Disease	MESH:D000544
38561809	326	328	AD	Disease	MESH:D000544
38561809	345	355	infections	Disease	MESH:D007239
38561809	359	374	gut dysfunction	Disease	MESH:C535334
38561809	385	388	LPS	Chemical	MESH:D008070
38561809	432	439	amyloid	Disease	MESH:C000718787
38561809	451	454	tau	Gene	4137
38561809	512	529	neurodegeneration	Disease	MESH:D019636
38561809	533	535	AD	Disease	MESH:D000544
38561809	616	619	LPS	Chemical	MESH:D008070
38561809	636	638	AD	Disease	MESH:D000544
38561809	639	647	patients	Species	9606
38561809	653	655	AD	Disease	MESH:D000544
38561809	678	681	LPS	Chemical	MESH:D008070
38561809	707	710	LPS	Chemical	MESH:D008070
38561809	719	724	Abeta	Gene	351
38561809	750	762	inflammation	Disease	MESH:D007249
38561809	767	780	neurotoxicity	Disease	MESH:D020258
38561809	786	789	LPS	Chemical	MESH:D008070
38561809	798	801	TAU	Gene	4137
38561809	849	852	LPS	Chemical	MESH:D008070
38561809	896	909	neurotoxicity	Disease	MESH:D020258
38561809	925	928	LPS	Chemical	MESH:D008070
38561809	977	979	AD	Disease	MESH:D000544
38561809	980	985	mouse	Species	10090
38561809	998	1019	cognitive dysfunction	Disease	MESH:D003072
38561809	1023	1029	humans	Species	9606
38561809	1111	1114	LPS	Chemical	MESH:D008070
38561809	1123	1125	AD	Disease	MESH:D000544
38561809	1154	1157	LPS	Chemical	MESH:D008070
38561809	1231	1241	infections	Disease	MESH:D007239
38561809	1305	1308	LPS	Chemical	MESH:D008070
38561809	1322	1325	LPS	Chemical	MESH:D008070
38561809	Association	MESH:D008070	MESH:C535334
38561809	Positive_Correlation	MESH:D008070	4137
38561809	Positive_Correlation	MESH:C535334	4137
38561809	Positive_Correlation	MESH:D008070	MESH:D003072
38561809	Positive_Correlation	MESH:D008070	MESH:C000718787
38561809	Association	MESH:D008070	MESH:D007239
38561809	Positive_Correlation	MESH:D008070	MESH:D000544
38561809	Positive_Correlation	MESH:D008070	MESH:D020258
38561809	Positive_Correlation	MESH:D008070	MESH:D019636
38561809	Positive_Correlation	MESH:D008070	MESH:D007249
38561809	Association	MESH:D019636	4137
38561809	Association	MESH:D000544	4137
38561809	Positive_Correlation	MESH:D008070	351

